Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 98,220 |
|
|||||
| News | - | ||||||
| Day High | 85.25 | Low High |
|||||
| Day Low | 84.64 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| VanEck Pharmaceuticals ETF | PPH | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| -0.32 | -0.38% | 84.87 | 16:00:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 85.11 | 84.64 | 85.25 | 84.87 | 85.19 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,098 | 98,220 | 84.99 | 8,347,631 | - | 74.05 - 91.16 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 16:54:37 | 1 | 86.45 | USD |
VanEck Pharmaceuticals ETF (PPH) Options Flow Summary
VanEck Pharmaceuticals ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 457.28M | 5.39M | - | 10.39M | 92.32M | 17.13 | 4.95 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News VanEck Pharmaceuticals ETF
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PPH Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 87.37 | 87.38 | 84.64 | 85.59 | 108,949 | -2.50 | -2.86% |
| 1 Month | 89.64 | 91.16 | 84.64 | 88.55 | 124,288 | -4.77 | -5.32% |
| 3 Months | 84.23 | 91.16 | 83.74 | 88.53 | 126,540 | 0.64 | 0.76% |
| 6 Months | 80.06 | 91.16 | 74.05 | 83.86 | 119,969 | 4.81 | 6.01% |
| 1 Year | 79.64 | 91.16 | 74.05 | 81.76 | 120,778 | 5.23 | 6.57% |
| 3 Years | 69.75 | 91.16 | 66.59 | 77.43 | 117,924 | 15.12 | 21.68% |
| 5 Years | 56.72 | 91.16 | 46.90 | 73.51 | 95,314 | 28.15 | 49.63% |
| The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. |
